Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Akorn, Inc. (NASDAQ: AKRX).

Full DD Report for AKRX

You must become a subscriber to view this report.


Recent News from (NASDAQ: AKRX)

Stock Exchange: Do You Buy At All Time Highs?
The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta...
Source: SeekingAlpha
Date: September, 07 2018 06:43
Merger Arbitrage Mondays - September 3, 2018
Merger activity remained unchanged last week with three new deals announced and three pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. There were two new deals announced in the Deals i...
Source: SeekingAlpha
Date: September, 04 2018 04:10
Tracking John Paulson's Paulson & Company Portfolio - Q2 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking John Paulson’s Paulson & Co...
Source: SeekingAlpha
Date: September, 02 2018 14:57
Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Akorn
NEW YORK, NY / ACCESSWIRE / August 24, 2018 / U.S. markets plunged on Thursday following the release of the minutes from the latest Federal Reserve meeting, which called for an interest hike in September. Investors appear to be focused on the upcoming speech from Federal Reserve Chairman Je...
Source: ACCESSWIRE IA
Date: August, 24 2018 08:00
Akorn down 16% as hearing ends
"Nobody should think they have a clean winner here," says the judge in the Akorn/Fresnius trial. More news on: Akorn, Inc., Fresenius Medical Care AG & Co. KGAA, Fresenius SE & Co. KGaA ADR, Merger & acquisition news, Healthcare stocks news, Stocks on the move, Read more .....
Source: SeekingAlpha
Date: August, 23 2018 15:06
Akorn down 12% ahead of hearing on disputed Fresenius merger
Investors are behaving like they expect bad news from today's post-trial hearing in Delaware related to Akorn's ( AKRX -11.7% ) dispute with former merger partner Fresenius Medical Care ( FMS -0.1% ) after the latter backed out of the $4.75B deal. Shares have retraced  17%  thi...
Source: SeekingAlpha
Date: August, 23 2018 12:43
Midday Gainers / Losers (08/23/2018)
Gainers: OBLN +45% . LEJU +27% . LX +24% . REED +17% . WSM +15% . SSC +13% . INSG +13% . DHX +13% . RAVN +12% . MOXC +11% . Losers: HMNY -27% . CATO -18% . PAVM -16% . LB -13% . YECO -7% . SMRT -13% . SYN -11% . AKRX -12% . CKPT ...
Source: SeekingAlpha
Date: August, 23 2018 12:40
Premarket analyst action - healthcare
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Overweight rating and $25 (79% upside) price target at Cantor Fitzgerald. Shares up  3%  premarket. More news on: ACADIA Pharmaceuticals Inc., Alder Biopharmaceuticals Inc., Halozyme Therapeutics, Inc., Healthcare stocks news,...
Source: SeekingAlpha
Date: August, 23 2018 08:21
FDA OKs first generic drug under new accelerated pathway
The FDA has approved Apotex's potassium chloride oral solution for the treatment and prevention of hypokalemia (low blood potassium) in patients on diuretics and when dietary management with potassium-rich foods is inadequate or diuretic dose reduction is not possible. More news on: Myla...
Source: SeekingAlpha
Date: August, 08 2018 11:38
Mylan's trimmed guidance may pressure generic drug makers
Mylan (NASDAQ: MYL ) is under modest pressure premarket, down  5%  on average volume, after cutting its 2018 guidance due to continued challenges in the U.S. market, a move that could stoke selling in the generics space. More news on: Mylan Inc, Teva Pharmaceutical Industries Lim...
Source: SeekingAlpha
Date: August, 08 2018 09:07

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0814.7114.7915.3914.6351,582,558
2018-05-1714.0114.2414.2513.8052,310,059
2017-06-2033.4833.4133.6233.381,129,667
2017-06-1933.5233.4533.5433.401,646,056
2017-06-1633.4633.4833.5433.381,842,377

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11310,052739,59041.9221Short
2018-12-10654,1691,450,10245.1119Short
2018-12-072,990,77310,900,45827.4371Cover
2018-12-061,090,6842,425,55744.9663Short
2018-12-04275,330637,66143.1781Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AKRX.


About Akorn, Inc. (NASDAQ: AKRX)

Logo for Akorn, Inc. (NASDAQ: AKRX)

Not available

 

Contact Information

 

 

Current Management

  • Bernard J. Pothast / CFO

Current Share Structure

  • Market Cap: $1,784,935,264 - 05/14/2018
  • Issue and Outstanding: 125,258,615 - 04/26/2018

 


Recent Filings from (NASDAQ: AKRX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: February, 14 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: February, 14 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: AKRX)

Daily Technical Chart for (NASDAQ: AKRX)


Stay tuned for daily updates and more on (NASDAQ: AKRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AKRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AKRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AKRX and does not buy, sell, or trade any shares of AKRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/